SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-025483
Filing Date
2023-07-24
Accepted
2023-07-24 17:13:04
Documents
15
Period of Report
2023-07-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crdf-20230724.htm   iXBRL 8-K 31247
2 EX-99.1 a991ex072423.htm EX-99.1 6196
6 crdf-20230724_g1.jpg GRAPHIC 2732
7 image_0a.jpg GRAPHIC 17928
  Complete submission text file 0001628280-23-025483.txt   192878

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crdf-20230724.xsd EX-101.SCH 1925
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crdf-20230724_lab.xml EX-101.LAB 22877
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crdf-20230724_pre.xml EX-101.PRE 12001
9 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20230724_htm.xml XML 2607
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 231105818
SIC: 2836 Biological Products, (No Diagnostic Substances)